Does UBIDECARENONE Cause Incorrect product administration duration? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Incorrect product administration duration have been filed in association with UBIDECARENONE (CO Q 10). This represents 2.5% of all adverse event reports for UBIDECARENONE.
9
Reports of Incorrect product administration duration with UBIDECARENONE
2.5%
of all UBIDECARENONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Incorrect product administration duration From UBIDECARENONE?
Of the 9 reports.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBIDECARENONE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does UBIDECARENONE Cause?
Drug ineffective (130)
Headache (125)
Pain (125)
Malaise (115)
Off label use (114)
Nausea (113)
Therapeutic product effect incomplete (113)
Abdominal pain (109)
Constipation (109)
Pyrexia (109)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which UBIDECARENONE Alternatives Have Lower Incorrect product administration duration Risk?
UBIDECARENONE vs UBLITUXIMAB
UBIDECARENONE vs UBLITUXIMAB-XIIY
UBIDECARENONE vs UBROGEPANT
UBIDECARENONE vs ULIPRISTAL
UBIDECARENONE vs UMBRALISIB